Deb Ranjan Banerjee

5PUBLICATIONS
3CO-AUTHORS
Biomolecular modelling and designGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsMolecular medicineEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Repurposing antifolates as G9a methyltransferase inhibitors for potential Alzheimer's disease therapeutics via 3D QSAR/pharmacophore mapping and experimental validations.

|Nov 17, 2023
Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer's Agent.

Abhisek Jana, Aina Bellver-Sanchis, Christian Griñán-Ferré

|May 22, 2023
Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a).

Abhisek Jana, Rahul Naga, Sougata Saha

|Oct 20, 2022
3D QSAR pharmacophore based lead identification of G9a lysine methyltransferase towards epigenetic therapeutics.

Abhisek Jana, Rahul Naga, Sougata Saha

|Aug 29, 2019
Chromatin Structure and the Pioneering Transcription Factor FOXA1 Regulate TDG-Mediated Removal of 5-Formylcytosine from DNA.

Charles E Deckard, Deb Ranjan Banerjee, Jonathan T Sczepanski

Pageof 1

Frequent Collaborators

2 joint publications

Christian Griñán-Ferré

1 joint publications

Jonathan T Sczepanski

1 joint publications

Aina Bellver-Sanchis